
Starkind Pharmaceuticals Private Limited
About Starkind Pharmaceuticals Private Limited
Data last updated:
Starkind Pharmaceuticals Private Limited was a private limited company based in Gorakhpur, Uttar Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 21 August 2012.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2012PTC052085.
The company had an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It was led by directors Dileep Kumar Mishra and Shailendra Dwivedi.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at H.No. – 657 Lachhipur Gorakhnath, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2021, the company reported a revenue of ₹10.48 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹1,934 (net margin 0.2%) and EBITDA of ₹2,613 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years.
Company details
Contact details
Starkind Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh.
- Registered AddressH.No. – 657 Lachhipur Gorakhnath, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Chemical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Starkind Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Starkind Pharmaceuticals Private Limited, buy the company report.
Financials of Starkind Pharmaceuticals Private Limited
FY 2021 filings availableStarkind Pharmaceuticals Private Limited reported revenue of ₹10.48 Lakh (down 24% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over three years, including a 24% fall in the latest year. EBITDA fell 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,613 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,934 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Starkind Pharmaceuticals Private Limited, buy the company report.
Board of directors of Starkind Pharmaceuticals Private Limited
Starkind Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dileep Kumar Mishra | Director | 21 Aug 2012 | 14 Years 3 Months | As last reported |
| Shailendra Dwivedi | Director | 21 Aug 2012 | 14 Years 3 Months | As last reported |
Peer comparison
Starkind Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arishta Pharmaceuticals Private Limited | ₹10.5 Lakh (FY 2018) | Panigaon, Assam, India | ||||
| Adobe Pharmaceuticals Private Limited | ₹10.49 Lakh (FY 2025) | 12.0% | Noida, Uttar Pradesh, India | |||
| Starkind Pharmaceuticals Private Limitedthis company | ₹10.48 Lakh (FY 2021) | ₹1,934 | 0.2% | -24.0% | Gorakhpur, Uttar Pradesh, India | |
| Azreal Pharmaceuticals Private Limited | ₹10.45 Lakh (FY 2024) | 575.0% | Indore, Madhya Pradesh, India | |||
| Aglow Pharmaceuticals Pvt. Ltd. | ₹10.43 Lakh (FY 2020) | -32.0% | Patna, Bihar, India | |||
| Agas Pharmaceuticals Private Limited | ₹10.42 Lakh (FY 2019) | -10.0% | Thrissur, Kerala, India |
To see the full peer comparison of Starkind Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Starkind Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Starkind Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Starkind Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Starkind Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Dileep Kumar Mishra was appointed as Director on 21 Aug 2012.
Frequently asked questions
Starkind Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Starkind Pharmaceuticals was a private limited company based in Gorakhpur, Uttar Pradesh, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 21 August 2012 and is registered under CIN U24233UP2012PTC052085. The company has been struck off by the Registrar of Companies and is no longer operational.
Starkind Pharmaceuticals had 2 directors:
- Dileep Kumar Mishra - Director
- Shailendra Dwivedi - Director
The CIN (Corporate Identification Number) of Starkind Pharmaceuticals is U24233UP2012PTC052085. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Starkind Pharmaceuticals is at H.No. – 657 Lachhipur Gorakhnath, Gorakhpur, Uttar Pradesh, India – 273001.
Starkind Pharmaceuticals was incorporated on 21 August 2012. It is registered with the Registrar of Companies, Kanpur.
The latest financial statements of Starkind Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
Starkind Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Starkind Pharmaceuticals by revenue are Arishta Pharmaceuticals Private Limited, Adobe Pharmaceuticals Private Limited, Azreal Pharmaceuticals Private Limited, Aglow Pharmaceuticals Pvt. Ltd, Agas Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Dileep Kumar Mishra was appointed as Director on 21 Aug 2012. Shailendra Dwivedi was appointed as Director on 21 Aug 2012.
The compliance status of Starkind Pharmaceuticals is active non-compliant as of 12 July 2026.

